Spectrum Pharmaceuticals, Inc. (SPPI)
Trading Center
Loading...
Symbols:
SPPI Forum Topics
- All Comments on SPPI
- General Discussion on SPPI
- Cancer Stocks on the Go: Winners and Losers [view article]
- Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
- Cancer Stocks Hammered Once Again [view article]
- Cancer Stocks Slide Again [view article]
- Cancer Stocks Plunge Following ASCO Meeting [view article]
- Cancer Stocks Soar With Annual ASCO Meeting [view article]
Recent SPPI Articles
- Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys?
- Cancer Stocks Finish a Tough Quarter
- Cancer Stocks: Tracking the Market
- Cancer Stocks: The Bleeding Slows
- Cancer Stocks Hammered Once Again
- Cancer Stocks Slide Again
- Cancer Stocks Plunge Following ASCO Meeting
- Cancer Stocks Soar With Annual ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
- Biotech Week in Review: Onyx Is Star of the Week
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
loading ...
Cancer Stocks on the Go: Winners and Losers [view article]
I agree with paviov, However I would like to know about the new developments the phase II and III studies that are going well, where is the advancement taking place, how close to a cure, what company has the potential winning drug ?? ReplyEditors
General Discussion on SPPI
Is this a buy or a sell? ReplyWhich Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
Banks don't scare you??! Amazing..I wouldn't think there is a predictable downside. Drug "discoveries"... are really very long, arduous drug development and testing scenarios... not like Financials which can blow billions early in the week. ReplyThe Wind
Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
I'm sticking with the bank(s). Drugs scare me - who knows how far down the road they'll discover some little thing that has very big repercussions? Sorry, but if Citi goes to 11, I'll cash in something else and just buy a bunch of Citi. And not that long ago, JPM was worth a whole lot less. And Bear was a whole lot more. But without the banks, who cares about the drugs? ReplyWhich Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
As a disclaimer I own a bunch of CEGE...for those interested in learning more about it go to the Yahoo quote on CEGE and hit message board..You will, of course, come across complete morons on occasion. On the other hand you'll find posting by some VERY astute people who have analyzed very deeply.As for anyone who thinks Citi can't go to $11...in June of 2007..LESS THAN A YEAR AGO..CITI WAS $52.50..HOW ABOUT SOME PEOPLE DOING A LITTLE DUE DILIGENCE??? Reply
Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
Excellent comparison - CITI vs CEGE. Who knows if FDA will approve GVAX but if they do $80 is not impossible. I remember CEGE over $50. Steve Sherwin is a bright guy working for the long haul. SPPI is also very interesting with multiple potential products and reasonable cash. ReplyWhich Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
The 10 billion market cap for CEGE is not that out of line if their GVAX drug is succesful. That may be a big if, but it would be proof of principal for GVAX in general, which is in clinical trials for two other types of cancer. If it works in one, it will probably work in others. ReplyWhich Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
PRAN will explode!!!Wait and see Reply
Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
I too think CEGE will be a long term winner. It is amazing how the shorts are manipulating many stocks today. The point that I liked about your piece was that we do not know but the "investment" could have much greater returns than past traditional investments. ReplyWhich Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
This article leaves one wondering if the author is truly naive to believe that one can hope to purchase C at $11, or if he is being disingenuous. And comparing it to a biotech hopeful!As Mr. Cramer says, if C ever does get to $11, too many folks will be backing up the proverbial truck. Or perhaps way before that. Reply
Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
There is nothing "silly" about the comparison..since the "author" is looking at risk/reward..not market caps or size. CEGE..which can easily be found out by any investor able to read...is in late stage clinical trials for a prostate cancer vaccine called GVAX. This vaccine may..MAY..also be applicable to other cancers..it's still early..but Takeda is a HUGE move for CEGE.How does any investor "know" "most assuredly" that Citi can't or won't go to $2 or $3...but then how could they? That would be like, well, Bear Stearns going from $50 to $2.... Reply
Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
Disclaimer First: I bought CEGE, based on reasonable Phase II results and a decent price / cash on balance sheet. The Takeda deal makes me more comfortable with my long position. That being said, I agree with Jose that the author would have been more informative if he put some numbers to his valuation. If GVAX is a success, then what is the realistic value of CEGE? I would love to read a well-informed article answering this question. ReplyMcintryre
Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys? [view article]
Nice corollary but silly to compare Citi with Cell Genesys. The author says he has a "good feel" for the odds of CEGE, but he doesn't say what they are or how he derived his good feel. So how can we judge whether CEGE an all or nothing biotech is a better risk/reward than Citigroup which is most assuredly not all or nothing?Should Cell Genesys fail its going way below $1 and if it succeeds, does the author really think it goes to a market cap of over $10B?
Get real Shulman. Go to Vegas, you'll have more fun and can catch a show. Reply
Cancer Stocks Hammered Once Again [view article]
Alan,What are your thoughts on Chemokine Therapeutics Corp (CHKT)?
And Meridian Co LTD (MRDAF)?
Reply
Cancer Stocks Hammered Once Again [view article]
please ignore the comment above. it was posted in the wrong thread.Reply